Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

HISTORICAL FACTS: Lly - The Untold Story

Ahead of Eli Lilly Earnings, Here's What Barchart Data Says Comes Next for LLY Stock

Eli Lilly is set to report its fiscal Q3 earnings on Oct. 29. Options data suggests the quarterly update will tank LLY shares.

Barchart · 19h ago

Dear Eli Lilly Stock Fans, Mark October 29 on Your Calendar

Eli Lilly’s weight-loss boom faces fierce competition, but its next earnings report could reveal why the best may still be ahead.

Barchart · Oct 26

LLY Stock Alert: What to Know as Eli Lilly Hits a New All-Time High

Eli Lilly stock printed a new all-time high yesterday. Here’s what has driven LLY shares higher and what comes next.

Barchart · Oct 21

From analysis to the latest developments in health,
read the most diverse news in one place.

How to Trade Eli Lilly Stock at New All-Time Highs

Eli Lilly (LLY) exhibits exceptional growth, profitability, and momentum, reaching a new all-time high today. Shares are up more than 60% over the past year. LLY maintains a 100% “Buy” technical opinion from Barchart. I recommend maintaining a rational stop loss given the stock’s momentum and volatility, despite continued analyst...

Barchart · Oct 20

What a Mixed Midterm Result Could Mean for These 2 Health Care ETFs

Polls suggest a divided government after the midterms, a scenario that historically benefits healthcare stocks. Here's how the XLV and IHF ETFs compare for investors eyeing the sector.

MarketBeat · Oct 19

Eli Lilly and Company Earnings Preview: What to Expect

Eli Lilly and Company is set to report its Q3 results soon, with analysts anticipating single-digit EPS growth alongside continued earnings growth.

Barchart · Oct 14

Only 20 Stocks Are Holding Up the Market: 3 Bargains Outside AI

Stansberry Research's Whitney Tilson argues record highs mask a bifurcated market, favoring Joby Aviation, Casey's General Stores, and Eli Lilly as value picks outside the AI trade.

MarketBeat · Oct 8

Read news from The Economist, FT, and more,
with one subscription

NVO vs. LLY: Novo’s CEO Says Confidence Is Gone. Lilly Is Winning 7 in 10 New Seniors.

Eli Lilly continues to outpace Novo Nordisk in the weight-loss market, supported by stronger patient growth and market share gains.

Barchart · Oct 5

4 Stocks That Could Split Next—and Why Investors Are Watching

AutoZone, Eli Lilly, Meta Platforms, and Costco all trade at high share prices, making them candidates for stock splits as analysts raise price targets and cite strong fundamentals.

MarketBeat · Sep 30

Eli Lilly Keeps Pulling Ahead—Can Novo Nordisk Catch Up?

Eli Lilly leads Novo Nordisk in GLP-1 market share and analyst sentiment, while Novo pins hopes on its CagriSema catalyst and pipeline to offset patent-cliff pressure and lawsuits.

MarketBeat · Sep 23

Eli Lilly vs. Novo: The Obesity-Drug Battle Is Entering Its Next Round

The obesity drug market is moving to the second phase, and only one appears to be better positioned to lead the second wave.

Barchart · Sep 21

5 Buy-and-Hold Stocks Built to Weather a Volatile Market

Ahead of Q4 2026, analysts favor Western Digital, NVIDIA, Vertiv, Eli Lilly, and JPMorgan Chase as steady, best-in-class stocks offering growth with less volatility for buy-and-hold investors.

MarketBeat · Sep 16

3 Healthcare Stocks for 3 Stages of Life

Healthcare stocks Eli Lilly, UnitedHealth Group, and Johnson & Johnson offer options for investors of different ages, combining growth potential, turnaround momentum, and reliable dividends.

MarketBeat · Sep 15

A $2.88 Billion Reason Why Eli Lilly Stock Is in Focus Today

Eli Lilly announced a $2.88 billion acquisition of Merida Biosciences. Here’s what it means for LLY shares.

Barchart · Aug 31

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart · Aug 28

Is Eli Lilly Stock Outperforming the Dow?

Outpacing the Dow over the past 12 months, Eli Lilly continues to receive a highly bullish outlook from Wall Street analysts, reflecting confidence in the company’s long-term prospects.

Barchart · Aug 6

Eli Lilly Stock: Analyst Estimates & Ratings

Eli Lilly's market-beating performance has done little to temper Wall Street's optimism, with analysts continuing to see meaningful upside in the stock.

Barchart · Aug 5

LLY Stock Alert: What to Know as Eli Lilly Teams Up With CVS on Weight-Loss Drugs

Eli Lilly shares rally on a fresh DTC partnership with CVS Health. A strong Q2 release and impressive future guidance is driving LLY stock higher as well.

Benzinga · Aug 5

Stock Market Today: S&P 500, Dow Futures Gain After Scott Bessent Signals Strait of Hormuz Deal With Iran in Sight— AMD, SpaceX, SanDisk in Focus (UPDATED)

(Editor’s note: The ETFs data was updated and economic data was added.)

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga · Aug 5

Stock Market: Will S&P 500 Open Up or Down Today?

The S&P 500 surged to a fresh record close on Tuesday as strong corporate earnings, easing oil prices and optimism over a potential breakthrough between the U.S. and Iran fueled another broad-based rally. Polymarket traders are now overwhelmingly betting the benchmark will extend those gains at Wednesday’s open.

Benzinga · Aug 4

Eli Lilly Could Swing $65.9 Billion After Earnings

Earnings are set to hit the tape in a tight window on Wednesday and the options market is already sketching out how much volatility traders are willing to pay for into the prints, according to Benzinga Pro.

Barchart · Aug 2

Earnings, PMI and Other Key Things to Watch this Week

Markets enter an earnings-dominated week with a huge concentration of corporate results spanning technology, industrials, healthcare, consumer discretionary, and entertainment sectors. This will provide a critical assessment of economic health and corporate fundamentals amid persistent uncertainty about technology sector valuations and AI infrastructure spending.

MarketBeat · Jul 22

Insider Moves Are Sending Mixed Signals Across the Tech Sector

Broadcom sees insider selling after volatile 2026 trading, while Netskope draws heavy insider buying post-earnings drop and Eli Lilly CEO David Ricks purchases Adobe shares.

Barchart · Jul 22

What You Need to Know Ahead of Eli Lilly's Earnings Release

Eli Lilly will release its second-quarter earnings next month, and analysts anticipate a double-digit bottom-line growth.

Barchart · Jul 16

Eli Lilly Is Buying AtaiBeckley in $2.8 Billion Deal. What It Means for LLY Stock

Eli Lilly stock rallies on a $2.8 billion acquisition of AtaiBeckley. Here’s why the deal is bullish for LLY shares.

Barchart · Jul 7

AbbVie vs Eli Lilly: 1 Is Clearly the Better Dividend Stock to Buy and Hold for the Next 10 Years

While one continues reinvesting for growth, the other has rewarded shareholders for 54 years in a row.

1 2 3 4 5

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations